{"id":121733,"date":"2017-06-13T11:19:35","date_gmt":"2017-06-13T11:19:35","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=121733"},"modified":"2017-06-13T11:19:35","modified_gmt":"2017-06-13T11:19:35","slug":"antipsychotic-drugs-market-2017-by-disease-type-geography-analysis-and-forecast-to-2021","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/antipsychotic-drugs-market-2017-by-disease-type-geography-analysis-and-forecast-to-2021_121733.html","title":{"rendered":"Antipsychotic Drugs Market 2017 by Disease Type, Geography, Analysis and Forecast to 2021"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“ReportsWeb”<\/div>\n<\/div>\n<\/div>\n
Antipsychotic Drugs Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.<\/div>\n

Antipsychotic drugs are also called as major tranquilizers or neuroleptics. These drugs are primarily used for the treatment of psychiatric disorders such as schizophrenia, hallucinations, delusions, bipolar disorder, and others. The antipsychotic drugs market is expected to grow due to the rising number of schizophrenic patients.<\/p>\n

Publisher’s analysts forecast the global antipsychotic drugs market to grow at a CAGR of 1.84% during the period 2017-2021.<\/p>\n

Complete Report Available at<\/strong> http:\/\/www.reportsweb.com\/global-antipsychotic-drugs-market-2017-2021<\/a> .<\/p>\n

Covered in this report <\/p>\n

The report covers the present scenario and the growth prospects of the global antipsychotic drugs market for 2017-2021. To calculate the market size, the report considers sales from both branded and generic drugs.<\/p>\n

The market is divided into the following segments based on geography: 
• Americas
• APAC
• EMEA<\/p>\n

Publisher’s report, Global Antipsychotic Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. <\/p>\n

Key vendors 
• AstraZeneca
• Eli Lilly
• GlaxoSmithKline
• Johnson & Johnson<\/p>\n

Get Sample of the Report at: <\/strong>http:\/\/www.reportsweb.com\/inquiry&RW0001830867\/sample<\/a> .                          <\/p>\n

Other prominent vendors <\/p>\n

• Actavis Generics (a subsidiary of Teva Pharmaceutical Industries)
• Alkermes
• Bristol-Myers Squibb<\/p>\n

Market driver 
• Increasing expenditure on prescription drugs
• For a full, detailed list, view our report <\/p>\n

Market challenge 
• Lack of standard diagnostic methods
• For a full, detailed list, view our report <\/p>\n

Market trend 
• Rising public interest toward mental health
• For a full, detailed list, view our report <\/p>\n

Inquire about Report at: <\/strong>http:\/\/www.reportsweb.com\/inquiry&RW0001830867\/buying<\/a> .                   <\/p>\n

Table of Contents:<\/strong><\/p>\n

PART 01: Executive summary<\/p>\n

PART 02: Scope of the report<\/p>\n

PART 03: Market research methodology<\/p>\n

PART 04: Introduction<\/p>\n

PART 05: Disease overview<\/p>\n

PART 06: Key clinical trials<\/p>\n

PART 07: Market landscape<\/p>\n

PART 08: Market segmentation by disease type<\/p>\n

PART 09: Market segmentation based on MoA<\/p>\n

PART 10: Geographical segmentation<\/p>\n

PART 11: Decision framework<\/p>\n

PART 12: Drivers and challenges<\/p>\n

PART 13: Market trends<\/p>\n

PART 14: Vendor landscape<\/p>\n

PART 15: Key vendor analysis<\/p>\n

PART 16: Appendix<\/p>\n

Purchase this Premium Research Report at: <\/strong>http:\/\/www.reportsweb.com\/buy&RW0001830867\/buy\/3500<\/a> .<\/strong> (Priced at US$ 3500).<\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> ReportsWeb
Contact Person:<\/strong> Rajat Sahni
Email:<\/strong> sam@reportsweb.com
Phone:<\/strong> +1-646-491-9876
Country:<\/strong> India
Website:<\/strong> http:\/\/www.reportsweb.com\/global-antipsychotic-drugs-market-2017-2021<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“ReportsWeb” Antipsychotic Drugs Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-121733","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/121733","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=121733"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/121733\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=121733"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=121733"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=121733"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}